Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

Fed Rate Hikes to Be Forced by Higher Wages: Amoroso
12:08 - Anastasia Amoroso, global market strategist at JPMorgan Asset Management, and University of Chicago Professor Luigi Zingales talk about the Federal Reserve's rate hike path and improving wages in the United States. They speak on "Bloomberg Surveillance." (Source: Bloomberg)
  • The Strength of the U.S. Dollar and the Global Economy
  • North Korean Rocket Test Launches Global Concern
  • U.S. Economy: Strong Consumers or Corporations?